Brexit deal: What it really means for cancer research and innovation

Europe/London GMT+1


Having left the EU during a global pandemic with a deal, the research and innovation landscape in the UK is set to change. This session will review the current situation and discuss how things are looking from the perspective of some key organisations and experts in the UK. Speakers will address challenges and opportunities and suggest what needs to happen to allow the UK to remain at the forefront of cancer research. Participants will get a better understanding of the current situation with regards to EU funding, grants and alternative research funding schemes. They will hear about current challenges and opportunities and learn what can be done to address them. Following the session, participants will have a clearer understanding of the changes and the choices to make to continue to attract funding and be successful in international collaborations.

Pamela Kearns

Brexit deal: What it really means for cancer research and innovation


Previous registration necessary?


Simultaneous translation ?


Will it be recorded?


Sheuli Porkess, Richard Sullivan, Emlyn Samuel, Jim Elliott


Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events


Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us


Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A Company
Site Managed by:
QUALITY Soluções Web
1996-2021 "25 years inspiring technology"